Prescription Drug Pricing

Prescription drug prices in America are far too high. As a result, 31 percent of Americans can’t afford to take their medications as prescribed. Recent reforms in the Inflation Reduction Act, including Medicare drug price negotiation, are making substantial progress toward lowering prescription drug prices, but there is still much work to do to help Americans afford the medications they need. The Center for American Progress analyzes and advocates for policy solutions to counteract the excessive prices set by pharmaceutical companies, including: advocating for direct price negotiation and price controls, combating manufacturer delay tactics, reforming the patent process, and promoting greater federal oversight and intervention.

Photo shows a closeup of a person's hands opening a bottle of pills, with a blue pill organizer sitting in front of them
A person with multiple sclerosis sorts prescription pills, June 2019. (Getty/Kurt Wittman/UCG/Universal Images Group)
Related Team
Health Policy

Latest

Compact View

CAP Responds to Request for Information on Consolidation in Health Care Markets Article

CAP Responds to Request for Information on Consolidation in Health Care Markets

The Center for American Progress submitted a response to the U.S. Department of Justice, Federal Trade Commission, and U.S. Department of Health and Human Services’ request for information on consolidation in health care markets.

Monthly Medicare Drug Price Negotiation Savings by State Interactive
Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy in Chicago.

Monthly Medicare Drug Price Negotiation Savings by State

Medicare drug price negotiation will result in thousands of dollars in net price savings for 30-day supplies of the first 10 drugs undergoing negotiation; here’s how those savings add up state by state.

Nicole Rapfogel

CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices Article

CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices

These briefs emphasize the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity.

CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices Article

CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices

This brief, filed by the Center for American Progress and the NAACP in response to Boehringer Ingelheim Pharmaceuticals Inc. v. U.S. Department of Health and Human Services et al., emphasizes the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity.

Load More

Related Issue

Strengthening Health

Strengthening Health

We work to strengthen public health systems and improve health care coverage, access, and affordability.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.